Safety of Lactobacillus Reuteri (L. Reuteri) in Healthy Adults

Completed · Phase 1 · Has a placebo group

Conditions studied: Colic, Gastrointestinal Tract Infections

In brief

This study will evaluate the safety and tolerability of the probiotic Lactobacillus reuteri (LR) in healthy adult patients. Patients will be randomized to receive either LR or placebo orally each day for a total of 60 doses. The effects on fecal bacteria, circulating white blood cell receptors and inflammatory cytokine profiles will be measured.

Key facts

Study ID
NCT00922727
Run by
The University of Texas Health Science Center, Houston
People needed
40
Starts
2009-10-01
Expected to finish
2011-07-01
Last updated by the study team
2018-01-25

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.